Name: Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy (en Inglés)
Price: 649432.00 COP
Availability: InStock
Author: Eksteen, Carla; Engelbrecht, Anna-Mart
ISBN: 9780443456480

portada Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy (en Inglés)

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy (en Inglés)

Formato

Libro Físico

Editorial

Academic Press

Autor

Eksteen, Carla; Engelbrecht, Anna-Mart

Idioma

Inglés

N° páginas

220

Encuadernación

Tapa Blanda

ISBN13

9780443456480

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy (en Inglés)

Eksteen, Carla; Engelbrecht, Anna-Mart (Autor) · Academic Press · Tapa Blanda

Libro Nuevo Importado

Envío: 53 a 61 días háb.

$ 1.298.865$ 649.432

-50%

Costos de importación incluídos en el precio ✅

Libro Nuevo

Quedan 50 unidades

$ 649.432

¡Envío Gratis! Llega entre el 13 Oct y el 26 Oct a Bogota, Cundinamarca. Seleccionar ubicación

Agregar a lista de deseos

Reseña del libro "Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy (en Inglés)"

Targeting the Triple Negative Breast Tumour Microenvironment to Overcome Resistance to Immunotherapy explores the critical role of the tumor microenvironment (TME) in driving immunotherapy resistance in triple-negative breast cancer (TNBC). It addresses the urgent need to understand and target the TME to improve therapeutic outcomes in this aggressive cancer subtype. The content gives insight into the complex interactions within the TME, including immune cells, fibroblasts, and extracellular matrix components, that contribute to drug resistance. It integrates recent advancements in 3D organoid platforms, spatial omics, and combination therapy strategies, providing mechanistic insights and practical approaches to reprogramming the TME for enhanced treatment response. Academics and clinicians benefit from a comprehensive resource that bridges basic science and clinical application. This book equips researchers with cutting-edge knowledge and translational strategies, fostering innovation in cancer therapy and offering a roadmap for future drug development to overcome immunotherapy resistance in TNBC.